Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Metals Regulatory News (FME)

  • There is currently no data for FME

Performance Rights Conversion

23 Nov 2023 08:15

RNS Number : 4607U
Future Metals NL
23 November 2023
 

23 November 2023

Future Metals NL

Performance Rights Conversion, Issue of Securities, Director Dealing and Change of Admission Date for Osprey Consideration Shares

Future Metals NL ("Future Metals" or the "Company", ASX|AIM: FME) announces, in accordance with the terms of the Company's Performance Rights Plan and the previous issue of Performance Rights approved by shareholders at the Company's general meeting held on 4 June 2021, that 1,966,666 Performance Rights have been converted at nil cost into 1,966,666 fully paid new ordinary shares of no par value each in the Company ("Ordinary Shares") by a Director and certain technical contractors of the Company (the "Conversion Shares") (the "Conversion").

800,000 Conversion Shares shall be issued to Mr Jardee Kininmonth, Managing Director & CEO of the Company. Following the Conversion, Mr Kininmonth will be interested in 1,588,605 Ordinary Shares, representing approximately 0.36% of the Company's issued share capital and further information of Mr other options and remaining Performance Rights held in the Company is set out the Appendix 3Y, available at the following link:

http://www.rns-pdf.londonstockexchange.com/rns/4607U_1-2023-11-23.pdf

Change of Admission Date for Osprey Consideration Shares

Future Metals also announces that, further to the Company's announcement on 17 November 2023, the admission of the 18,382,352 Consideration Shares (as defined in such announcement) to trading on AIM is now expected to occur at 8.00 a.m. on or around 24 November 2023.

Admission to Trading on AIM and Total Voting Rights

Application has been made to the London Stock Exchange plc for the admission to trading on AIM of the abovementioned 18,382,352 Consideration Shares on 24 November 2023 and for the admission of the 1,966,666 Conversion Shares on 28 November 2023 ("Admission"). Admission is expected to take effect and dealings commence at 8.00 a.m. (London time) on or around 24 and 28 November 2023, respectively.

Following admission of the Consideration Shares, the number of Ordinary Shares in issue, and the total voting rights in the Company will be 440,253,055. Following admission of the Conversion Shares, the number of Ordinary Shares in issue, and the total voting rights in the Company will be 442,219,721. These figures may be used by shareholders as the denominator for the calculations by which they determine whether they are required to notify their interest in, or a change of their interest in, the Company under the provisions of the Company's constitution. 

This announcement has been approved for release by the Board of Future Metals NL.

Further Information

 

For further information please refer to the ASX platform under ASX code FME or visit the Company's website at www.future-metals.com.au.

 

Future Metals NL

+61 8 9480 0414

Jardee Kininmonth

info@future-metals.com.au

Strand Hanson Limited (Nominated Adviser)

+44 (0) 207 409 3494

James Harris/James Bellman

Panmure Gordon (UK) Limited (UK Broker)

John Prior/Hugh Rich/Rauf Munir

+44 (0)207 886 2500

FlowComms (UK IR/PR)

+44 (0) 789 167 7441

Sasha Sethi

 

PDMR Notification Form:

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jardee Kininmonth

2.

Reason for the Notification

a)

Position/status

Managing Director & CEO

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Future Metals NL

b)

LEI

213800WZ1MNQPOAKNU50

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

AU0000157745

b)

Nature of the Transaction

Conversion of performance rights into new Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

800,000

d)

Aggregated information

Aggregated volume Price

N/A (Single transaction)

e)

Date of the transaction

21 November 2023

f)

Place of the transaction

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCVXLBLXFLFFBL
Date   Source Headline
5th Nov 20257:00 amRNSCancellation - Future Metals NL
31st Oct 20256:00 pmRNSFuture Metals NL
30th Oct 20257:00 amRNSQuarterly Activities Report
24th Oct 20259:00 amRNSNotice of AGM
7th Oct 20258:46 amRNSCancellation of Admission to AIM
29th Sep 20258:06 amRNSAppointment of Managing Director and CEO
26th Sep 20259:06 amRNSFinal Results for the Year Ended 30 June 2025
30th Jul 20257:00 amRNSQuarterly Activities Report
16th Jul 20257:00 amRNSDirector / PDMR Dealing
11th Jul 20258:37 amRNSSignificant Shareholder Interest
20th Jun 20258:00 amRNSResults of Non-Renounceable Entitlement Offer
4th Jun 20257:00 amRNSEntitlement Offer Fully Underwritten
27th May 20259:17 amRNSEntitlement Offer – Extension of Closing Date
15th May 20257:01 amRNSEntitlement Offer Details for DI Holders
15th May 20257:00 amRNSCommencement of Entitlement Offer
7th May 20257:15 amRNSLaunch of A$2.64m (£1.28m) Entitlement Offer
30th Apr 20257:00 amRNSQuarterly Activities Report
23rd Apr 20259:04 amRNSCompletion of Placement
10th Apr 20257:00 amRNSStrategic Infrastructure MOU and Equity Fundraise
8th Apr 20258:01 amRNSASX Trading Halt
12th Mar 202512:54 pmRNSResults for the Half-Year Ended 31 December 2024
17th Feb 20257:01 amRNSASX Price Query Response
17th Feb 20257:00 amRNSCompany Update
30th Jan 20257:00 amRNSQuarterly Activities Report
19th Dec 20247:00 amRNSChange of Company Secretary
21st Nov 20241:01 pmRNSResult of AGM and Board Changes
11th Nov 20248:48 amRNSResignation of Non-Executive Director
31st Oct 20249:25 amRNSQuarterly Activities Report
30th Oct 202412:00 pmRNSReplacement: Company Update
29th Oct 20247:00 amRNSCompany Update
18th Oct 20248:00 amRNSNotice of AGM
11th Oct 20247:00 amRNS2024 AGM and Director Nominations
9th Oct 20247:00 amRNSDrilling Underway at Eileen Bore
30th Sep 20241:30 pmRNSFinal Results for the Year Ended 30 June 2024
16th Sep 20247:00 amRNSHeritage Surveys Completed & Testing Eileen Bore
21st Aug 20247:00 amRNSResults of the Option Offer and Shortfall
9th Aug 20248:07 amRNSCompany Update
31st Jul 20248:00 amRNSOption Offer
29th Jul 20249:30 amRNSQuarterly Activities Report
4th Jul 20243:01 pmRNSChange of Auditor & Issue of Underwriter Options
3rd Jul 20242:16 pmRNSGrant of Director Performance Rights
2nd Jul 202412:45 pmRNSIssue of Equity and Change of Registered Office
25th Jun 20249:00 amRNSResults of General Meeting
12th Jun 20247:00 amRNSExercise of Quoted Options
24th May 20247:00 amRNSNotice of General Meeting
22nd May 20248:30 amRNSRelease of Securities from Voluntary Escrow
21st May 20249:22 amRNSIssue of Consideration Shares
14th May 20247:00 amRNSReceipt of A$180,000 EIS Grant
10th May 20248:00 amRNSNotification of Expiry of Quoted Options
3rd May 202410:15 amRNSProposed Options Entitlement Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.